ストックスクリーナーアプリを入手
1.05
8.70%
-0.10
アフターアワーズ：
1.10
0.05
+4.76%
前日終値:
$1.15
開ける：
$1.19
24時間の取引高:
242.14K
Relative Volume:
1.29
時価総額：
$6.22M
収益：
-
当期純損益:
$-15.52M
株価収益率:
-0.0565
EPS:
-18.58
ネットキャッシュフロー:
$-16.61M
1週間 パフォーマンス:
+1.45%
1か月 パフォーマンス:
+6.92%
6か月 パフォーマンス:
+30.43%
1年 パフォーマンス:
-84.09%
1日の値動き範囲:
$1.01
$1.19
1週間の範囲:
$1.01
$1.20
52週間の値動き範囲:
$0.702
$20.16
Revelation Biosciences Inc Stock (REVB) Company Profile
名前
Revelation Biosciences Inc
セクター
電話
650-800-3717
住所
4660 LAJOLLA VILLAGE DRIVE, SAN DIEGO
REVB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
REVB
Revelation Biosciences Inc
|
1.05 | 6.81M | 0 | -15.52M | -16.61M | -18.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Revelation Biosciences Inc (REVB) 最新ニュース
Revelation Biosciences sets warrant expiration after stockholder approval - Investing.com
Why Revelation Biosciences Inc. stock remains a top recommendationJuly 2025 PostEarnings & Weekly Watchlist for Hot Stocks - Newser
Revelation Biosciences Has Reached A Quorum For Its December 3, 2025 Special Meeting - azcentral.com and The Arizona Republic
Revelation Biosciences shareholders approve warrant issuance and meeting adjournment By Investing.com - Investing.com Canada
Revelation Biosciences, Inc. (REVB) -5.1% in After-hours: Amid Routine Trading Conditions - Stocks Telegraph
Revelation Biosciences shareholders approve warrant issuance and meeting adjournment - Investing.com
Revelation Biosciences (REVB) Stock Analysis Report | Financials & Insights - Benzinga
Revelation Biosciences (NASDAQ: REVB) secures quorum ahead of Dec. 3 vote, notes $9.6M proceeds - Stock Titan
Revelation Biosciences on track for end-of-phase 1 meeting later this year - MSN
Revelation Biosciences (NASDAQ:REVB) Shares Up 2.4% – Here’s Why - Defense World
Revelation Biosciences, Inc. (REVB) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Earnings Flash (REVB) Revolution Beauty Group Reports Fiscal H1 Revenue GBP49.4M - marketscreener.com
Revelation Biosciences Inc. Announces Cancellation of Adjournment of October 29, 2025 Special Meeting of Stockholders and New Record Date - The State Journal-Register
Revelation Biosciences On Track for End-of-Phase 1 Meeting With FDA Later This Year - The Courier-Journal
Can Revelation Biosciences Inc. Equity Warrant stock sustain free cash flow growthLong Setup & Accurate Entry/Exit Alerts - newser.com
How Revelation Biosciences Inc. stock reacts to global recession fearsJuly 2025 News Drivers & High Accuracy Investment Signals - newser.com
Revelation Biosciences submits end-of-phase 1 package to FDA By Investing.com - Investing.com Australia
Revelation Says On Track for FDA Meeting Later This Year - MarketScreener
Revelation Biosciences submits end-of-phase 1 package to FDA - Investing.com
Revelation Biosciences (NASDAQ: REVB) Advances Gemini AKI Program With FDA Phase 1 Meeting - Stock Titan
Chart based analysis of Revelation Biosciences Inc. Equity Warrant trends2025 Valuation Update & Precise Buy Zone Identification - newser.com
How Revelation Biosciences Inc. Equity Warrant stock performs in weak economyGold Moves & Short-Term Trading Alerts - newser.com
How Revelation Biosciences Inc. Equity Warrant stock reacts to oil pricesWall Street Watch & Fast Gaining Stock Strategy Reports - newser.com
How institutional buying supports Revelation Biosciences Inc. Equity Warrant stockWeekly Trend Report & Intraday High Probability Setup Alerts - newser.com
Using RSI to spot recovery in Revelation Biosciences Inc. Equity Warrant2025 Market Trends & Expert Curated Trade Ideas - newser.com
Using Bollinger Bands to evaluate Revelation Biosciences Inc. Equity Warrant2025 Volume Leaders & High Conviction Investment Ideas - newser.com
Revelation Biosciences Inc (REVB) 財務データ
収益
当期純利益
現金流量
EPS
1.08%
0.91%
大文字化:
|
ボリューム (24 時間):